ImmunityBio IBRX Market Impact ImmunityBio Posts 374 EPS Beat Narrowing Losses CREX CreativeReal posts wider than expected Q4 2025 loss even as its shares rise modestly in trading today Why Silicon Laboratories SLAB deserves more attention from serious investors Underperforming 20260511 Generative AI Adoption Risks in Regulated Professional Services First FBIZ Stock Trading at Premium Hovering 20260422 DuPont Q1 2026 Earnings EPS Surprise Lifts Shares ON24 Q4 2025 Earnings EPS Surges 151 Above Estimates as Operational Efficiencies Pay Off CCAP Q1 2026 Earnings Narrow EPS Miss Amid Steady Portfolio Performance PANW Q1 2026 Earnings EPS Surpasses Estimates Stock Rises MRT Q4 2025 Earnings Narrower Loss Surprises Market Stock Slightly Dips SREA Q1 2026 Earnings Earnings Per Share Slightly Misses Consensus Notes Edge Higher